Stock SANN SANTHERA PHARMACEUTICALS HOLDING AG
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Santhera Pharmaceuticals Holding AG

Equities

SANN

CH1276028821

Market Closed - Swiss Exchange
Other stock markets
 11:31:51 2024-07-05 am EDT 		5-day change 1st Jan Change
8.29 CHF -1.54% Intraday chart for Santhera Pharmaceuticals Holding AG -0.24% -15.49%
Jun. 19 Transcript : Santhera Pharmaceuticals Holding AG - Special Call
Jun. 18 Santhera Secures CHF69 Million Financing for Bond Repayment, Cash Runway Extension MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Santhera Pharmaceuticals Names Chief Commercial, Technology Officers
MT
Santhera Pharmaceuticals Holding Ag Promotes Promotion of Geert Jan Van Daal to Chief Commercial Officer and of Marc Schrader to Chief Technology Officer
CI
Santhera Pharmaceuticals Holding AG Announces Executive Changes
CI
Santhera Pharmaceuticals Holding AG Announces Board Changes
CI
Santhera Pharmaceuticals Holding AG Announces that Elmar Schnee will not stand for re-election at the upcoming Annual General Meeting
CI
Santhera Pharmaceuticals Names New Chief Medical Officer
MT
Santhera Pharmaceuticals Holding AG Appoints Shabir Hasham as Chief Medical Officer and a Member of Santhera’s Executive Management Team, Effective May 1, 2022
CI
Santhera Pharmaceuticals Holding AG Appoints Stephanie Brown as President North America and Member of Executive Management, Effective December 1, 2021
CI
Santhera Announces Departure of Kristina Sjöblom Nygren, Chief Medical Officer and Head of Development
CI
Santhera Pharmaceuticals Approves New Members of the Compensation Committee
CI
Santhera Pharmaceuticals Holding AG Announces Appointment of Andrew Smith as CFO and Member of the Executive Management Team, Effective April 1, 2020
CI
Santhera Pharmaceuticals Appoints Dario Eklund as CEO and to Chair of Board of Director’s Scientific Committee
CI
Christoph Rentsch to Step Down as Chief Financial Officer of Santhera Pharmaceuticals
CI
Jürg Ambühl Decides Not to Stand for Re-Election to the Board of Santhera Pharmaceuticals Holding AG
CI
Santhera Pharmaceuticals Opens of U.S. Office in Burlington, MA; Appoints Todd Bazemore to Lead U.S. Operations in Burlington, MA
CI
Santhera Pharmaceuticals Holding AG Announces Nomination of Directors
CI
Santhera Pharmaceuticals Announces Executive Changes
CI
Santhera Pharmaceuticals Holding AG Appoints as CFO and Member of the Executive Management Team
CI
Santhera Pharmaceuticals Announces Management Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SANN Stock
  4. News Santhera Pharmaceuticals Holding AG
  5. Insiders